Immune complex clearance by complement receptor type 1 in SLE

Autoimmunity Reviews

Volumn 8, Issue 2, 2008, Pages 160-164

  Kavai, Maria ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Clearance; Complement receptor 1; Immune complex; SLE

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C3B RECEPTOR; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN EXPRESSION; BINDING SITE; COMPLEMENT ACTIVATION; ERYTHROPOIESIS; GENETIC POLYMORPHISM; HUMAN; LIGAND BINDING; LUPUS ERYTHEMATOSUS NEPHRITIS; PLASMAPHERESIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIGEN-ANTIBODY COMPLEX; COMPLEMENT ACTIVATION; ERYTHROCYTES; ERYTHROPOIETIN, RECOMBINANT; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PLASMAPHERESIS; RECEPTORS, COMPLEMENT;

EID: 56349159793     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.06.002     Document Type: Review

References (40)

1. Hochberg M.C. Updating the American Collage of Rheumatology revised criteria for classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40 (1997) 1725
2. Stanilova S.A., and Slavov E.S. Comparative study of circulating immune complexes quantity detection by assays: CIF-ELISA, C1q-ELISA and anti-C3-ELISA. J Immunol Methods 253 (2001) 13-21
3. Kávai M., and Szegedi G.Y. mmune complex clearance by monocytes and macrophages in systemic lupus erythematosus. Autoimmunity Reviews 6 (2007) 497-502
4. Katyal M., Tiwari S.C., Kumar A., Dinda A.K., Arora V., Kumar R., et al. Association of complement receptor 1 (CR1, CD35, C3b/C4b receptor) density polymorphism with glomerulonephritis in Indian subjects. Mol Immunol 40 (2004) 1325-1332
5. Lindorfer M.A., Nardin A., Foley P.L., Solga M.D., Barankovich J., Nardin A., et al. Targeting of Pseudomonas aerugionosa in the bloodstream with bispecific monoclonal antibodies. J Immunol 167 (2001) 2240-2249
6. Taylor R.P., Horgan C., Buschbacher R., Brunner C., Hess M., O'Brien W.M., et al. Decreased complement mediated binding of antibody 3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum 26 (1983) 736-744
7. Cohen J.H.M., Lutz H.U., Pennaforte J.L., Bouchard A., and Kazatchkine M.D. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 87 (1992) 422-428
8. Schifferli J.A., Ng Y.C., Estreicher J., and Nalport M.J. The role of hypocomplementaemia and low erythrocyte complement receptor 1 numbers in determining abnormal immune complex clearance in humans. Clin exp Immunol 35 (1989) 993-1003
9. Falus A., Füst G., and Erdei A. Complement research - biosynthesis, genetics, immunoregulatory role and clinical - studies. Immunol Today 13 (1992) A10-A12
10. Medgyesi G.A., Miklos K., Kulics J., Füst G., Gergely J., and Bazin H. Class and subclasses of rat antibodies: reaction with the antigen and interaction of the complex with the complement system. Immunology 43 (1981) 171-176
11. Taylor R.P., Edberg J.C., Kujala G.A., Sloman A.J., Wilson C.C., and Cronin M.E. The interaction of antibody/DNA immune complexes with complement. Influence of antibody class and DNA formation. Arthritis Rheum 30 (1987) 176-185
12. Jepsen H.H., Svehag S.E., Jarlbaek J.C., and Baatrup G. Interaction of complement-solubilized immune complexes with CR1 receptors on human erythrocytes. The binding reaction. Scand J Immunol 23 (1986) 65-73
13. Kávai M., Möller-Rasmussen J.M., Baatrup G., Zsindely A., and Svehag S.E. Inefficient binding of IgM immune complexes to erythrocyte C3b-C4b receptors (CR1) and weak incorporation of C3b-iC3b into the complexes. Scand J Immunol 28 (1988) 123-128
14. Taylor R.P., Wright E.L., and Pocanic F. Quantitative analyses of C3b capture and immune adherence of IgM antibody/dsDNA immune complexes. J Immunol 143 (1989) 3626-3631
15. Manderson A.P., Quash B., Botto M., Goodnow C.C., Walport M.J., and Parish C.R. A novel mechanism for complement activation at the surface of B cells following antigen binding. J Immunol 177 (2006) 5155-5162
16. Mazocchi-Machado C.M., Polizello A.C.M., Azzolini A.E.C.S., and Lucisano-Valim Y.M. The influence of antibody functional affinity on the effector functions involved in the clearance of circulating immune complex anti-BSA IgG/BSA. Immunol Invest 28 (1999) 89-101
17. Wilson J.G., Wong W.W., Murphy E.E.I.I.I., Schur P.H., and Fearon D.T. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene. J Immunol 138 (1987) 2706-2710
18. Moldenhauer F., Botto M., and Walort M.J. The rate of loss of CR1 from aging erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphism. Clin Exp Immunol 72 (1988) 74-78
19. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
20. Cornillet P., Philbert F., Kazatchkine M.D., and Cohen J.H.M. Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion. J Immunol Methods 136 (1991) 193-197
21. Kiss E., Csipö I., Cohen J.H.M., Reveil B., Szegedi G.Y., and Kávai M. CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus. Autoimmunity 25 (1996) 53-58
22. Mok C.C., and Lau C.S. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 56 (2003) 481-490
23. Nath S.K., Harley J.B., and Lee Y.H. Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus. Hum Genet 118 (2005) 225-234
24. Clark W.F., Dan P.C., Euler H.H., Guillevin L., Harford J., Heer A.H., et al. Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus; design of the LPSG trial. J Clin Apheresis 6 (1991) 40-47
25. Fan Q., Uring-Lambert B., Weill B., Gautreau C., Menkes C.J., and Delpech M. Complement component C4 deficiencies and gene alterations in patients with systemic lupus erythematosus. Eur J Immunogenet 1 (1993) 11-21
26. Csípo{double acute} I., Kávai M., Kiss E., Bedo{double acute} Z., Csongor J., Szegedi G.Y., et al. Serum complement activation of SLE patients during plasmapheresis. Autoimmunity 25 (1997) 139-146
27. Zimmermann-Nielsen E., Svehag S.E., Thorlacius-Ussing O., and Baatrup G. ELISA for evaluation the incorporation of plasma derived complement split-products C3b/iC3b into solid-phase immune complexes. J Immunol Methods 249 (2001) 43-51
28. Soltesz P., Aleksza M., Antal-Szalmas P., Lakos G., Szegedi G.Y., and Kiss E. Plasmapheresis modulates TH1/TH2 imbalance in patients with systemic lupus erythematosus according to measurement of intracytoplasmic cytokines. Autoimmunity 35 (2002) 51-56
29. Bambardier C., Gladman D.D., and Urowitz M.B. Derivation of SLE DAI. A disease activity index for lupus patients. Arthritis Rheum 35 (1992) 630-640
30. Edberg J.C., Kimberly R.P., and Taylor R.P. Functional characterization of non-human primate erythrocyte immune complex receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system. Eur J Immunol 22 (1992) 1333-1339
31. Csípo{double acute} I., Kiss E., Soltész P., Antal-Szalmás P., Szegedi G.Y., Cohen J.H.M., et al. Effect of plasmapheresis in ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 118 (1999) 458-464
32. Kuhn S.E., Nardin A., Klebba P.E., and Taylor R.P. Escherichia coli bound to primate erythrocyte complement receptor via bispecific monoclonal antibodies transfer to and phagocytosed by human monocytes in an in vitro model. J Immunol 160 (1998) 5088-5097
33. Peeters H.R.M., Jongen-Lavrencic M., and Vrengdenhil G. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double binding 52 weeks clinical trial. Ann Rheum Dis 55 (1996) 739-744
34. Hebert L.A., Birmingham D.J., hen X.P., and Cosio F.G. Stimulating erythropoiesis increases complement receptor expression on primate erythrocytes. Clin Immunol Immunopathol 62 (1992) 3010-3306
35. Kiss E., Kávai M., Csipo{double acute} I., and Szegedi G.Y. Clinical and immunomodulatory effects of erythropoietin alpha in chronic anaemia of patients with systemic lupus erythematosus. Erythropoesis 8 (1997) 74-79
36. Kiss E., Kávai M., Csipo{double acute} I., and Szgedi G.Y. Recombinant human erythropoietin modulates erythrocyte complement receptor 1 functional activity in patients with lupus nephritis. Clin Nephrol 49 (1998) 364-369
37. Pascual M., Duchosal M.A., Steiger G., Giostra E., Pechere A., Paccaud J.P., et al. Circulating soluble CR1 (CD35): serum levels in diseases and evidence for its release by human leukocytes. J Immunol 151 (1993) 1702-1711
38. Craig M.L., Waitumbi J.N., and Taylor R.P. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1. J Immunol 174 (2005) 3059-3066
39. Csipo I., Kiss E., Bako E., Szegedi G.Y., and Kavai M. Soluble complement receptor 1 (CD35) bound to immune complex in sera of patients with systemic lupus erythematosus. Arthritis Rheum 52 (2005) 2950-2951
40. Sadallah S., Hess C., Trendelenburg M., Vedeler C., Lopez-Trescasa M., and Schifferli J.A. Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients. Clin Exp Immunol 131 (2003) 174-181